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Abstract
Introduction Acid–base abnormalities are common in the
intensive care unit (ICU). Differences in outcome exist between
respiratory and metabolic acidosis in similar pH ranges. Some
forms of metabolic acidosis (for example, lactate) seem to have
worse outcomes than others (for example, chloride). The relative
incidence of each type of disorder is unknown. We therefore
designed this study to determine the nature and clinical
significance of metabolic acidosis in critically ill patients.
Methods An observational, cohort study of critically ill patients
was performed in a tertiary care hospital. Critically ill patients
were selected on the clinical suspicion of the presence of lactic
acidosis. The inpatient mortality of the entire group was 14%,
with a length of stay in hospital of 12 days and a length of stay
in the ICU of 5.8 days.
Results We reviewed records of 9,799 patients admitted to the
ICUs at our institution between 1 January 2001 and 30 June
2002. We selected a cohort in which clinicians caring for
patients ordered a measurement of arterial lactate level. We
excluded patients in which any necessary variable required to
characterize an acid–base disorder was absent. A total of 851
patients (9% of ICU admissions) met our criteria. Of these, 548
patients (64%) had a metabolic acidosis (standard base excess
< -2 mEq/l) and these patients had a 45% mortality, compared
with 25% for those with no metabolic acidosis (p < 0.001). We
then subclassified metabolic acidosis cases on the basis of the
predominant anion present (lactate, chloride, or all other anions).
The mortality rate was highest for lactic acidosis (56%); for
strong ion gap (SIG) acidosis it was 39% and for
hyperchloremic acidosis 29% (p < 0.001). A stepwise logistic
regression model identified serum lactate, SIG, phosphate, and
age as independent predictors of mortality.
Conclusion In critically ill patients in which a measurement of
lactate level was ordered, lactate and SIG were strong
independent predictors of mortality when they were the major
source of metabolic acidosis. Overall, patients with metabolic
acidosis were nearly twice as likely to die as patients without
metabolic acidosis.
Introduction
An inconsistent relationship has been reported between acid–
base abnormalities, their treatment, and outcomes [1-6] in crit-
ically ill patients. Some studies have suggested an independ-
ent association between low pH or standard base excess
(SBE) and mortality [7-9], whereas others have not [1,10].
We have recently shown that hemodynamically stable rats with
sepsis become hypotensive after infusion of dilute HCl [11].
Similarly we have found decreased survival time in rats with
elevated serum chloride levels that were exposed to lethal
doses of lipopolysaccharide [12], as well as different cytokine
responses to acidosis induced by lactate or HCl in cell cul-
ABG = arterial blood gas; AGc = corrected anion gap; ICU = intensive care unit; pCO2 = partial pressure of carbon dioxide; pO2 = partial pressure 
of oxygen; SBE = standard base excess; SID = strong ion difference; SIDa = apparent strong ion difference; SIDe = effective strong ion difference; 
SIG = strong ion gap.
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tures [13]. We therefore propose that the etiologic anion of
metabolic acidosis (lactate, chloride, or others) may be a more
important determinant of outcome than the pH itself.
Although lactic acidosis has attracted considerable study in
critically ill patients, metabolic acidosis can result from a vari-
ety of conditions [14]. Although the existing literature does not
suggest a strong relationship between the type of acidosis
and outcome, traditional methods of classifying and analyzing
acid–base abnormalities have significant limitations, especially
in critically ill patients [15]. In particular, studies have usually
failed to identify the effects that causative anions (for example
lactate, chloride, or all others) have on their resulting pH and
SBE. Data may be reported as 'non-lactate metabolic acidosis'
or 'anion gap metabolic acidosis' without identifying a predom-
inant source. By using a physical–chemical approach [16-18]
to quantify unmeasured anions accurately, coupled with multi-
variable logistic regression, we believe that a more rigorous
characterization of acid–base disorders and their clinical sig-
nificance can be achieved. Our objective was to determine the
effect of different etiologies of metabolic acidosis on hospital
mortality and length of stay in critically ill patients suspected of
having lactic acidosis. The hypothesis was that the various eti-
ologies of metabolic acidosis have unique mortality and mor-
bidity rates associated with them.
Materials and methods
Rationale
Our intent was to identify a cohort of patients in which lactic
acidosis was suspected but for whom other acid–base abnor-
malities might be present. Focusing on this group of patients
permitted us to limit our analysis to a subgroup with a high inci-
dence of metabolic acidosis and a high risk of death. Describ-
ing the incidence and impact of various forms of acidosis in
this cohort is potentially more clinically relevant than in the
entire intensive care unit (ICU) population.
We divided this cohort into two groups depending on the
presence or absence of a metabolic acidosis, where SBE < -
2 mEq/l determined metabolic acidosis. The metabolic acido-
sis group was further subdivided into groups depending on
the anion contributing to the majority of the acidosis.
Data abstraction
After approval from the Investigational Review Board of the
University of Pittsburgh we searched the database of Medical
Archival Systems Inc. (Pittsburgh, PA, USA) from 1 January
2001 to 30 June 2002 for all ICU admissions at the University
of Pittsburgh Medical Center, Oakland, PA. We selected
cases on the following criteria. First, clinicians caring for each
patient suspected the presence of lactic acidosis and
obtained an analysis for arterial blood gas (ABG) and serum
lactate. In the hospitals included in this study, to obtain a lac-
tate level a physician has to order one specifically. There are
no routine, standing orders or protocols for lactate measure-
ment. Thus, blood lactate measurements are usually obtained
only when there is a suspicion of lactic acidosis. Next, to
account for all ions, electrolytes had to be drawn within four
hours (0.8 ± 2, mean ± SD) hours), and calcium, magnesium
and phosphorus within 24 hours (mean 1.3 ± 4.6 hours) of the
referenced ABG and an albumin level at some time during the
hospitalization. If more than one albumin value was recorded,
the lowest value was used to avoid spurious elevations due to
possible resuscitation with albumin. If the patient had more
than one ABG that fitted these criteria, the ABG with the high-
est lactate level was used. Finally, if there was more than one
data set of electrolytes that fitted around the index ABG, the
data set with an absolute time frame closest to the indexed
Figure 1
Mortality associated with the major ion contributing to the metabolic acidosis. Hospital mortality associated with the various etiologies of metabolic 
acidosis (standard base excess (SBE) < -2). Mortality percentage is mortality within each subgroup, not a percentage of overall mortality. 'Lactate' 
indicates that lactate contributes to at least 50% of the SBE; 'SIG', SIG contributes to at least 50% of SBE (and not lactate); 'hyperchloremic', 
absence of lactate or SIG acidosis and SBE < -2; 'none', no metabolic acidosis (SBE ≥ -2 mEq/l). SIG, strong ion gap. p < 0.001 for the four-group 
comparison.
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ABG was used. Data could be collected at any time that the
patient fitted these criteria. A few patients might have actually
had the highest lactate level while in the Emergency Depart-
ment or on the general wards; however, we included only
patients who were ultimately admitted to an ICU.
Measurements, calculations, and classification of 
metabolic acidosis
All samples were analyzed in the hospital's central laboratory
(Vitros 950; Ortho-Clinical Diagnostics, Raritan, NJ, USA) or
blood gas laboratory (Radiometer-ABL 725; Radiometer,
Copenhagen, Denmark) for processing. Serum samples were
collected in a serum separator tube and sent to the central lab-
oratory for processing. Blood gas samples were collected in a
sodium heparin syringe and sent to the blood gas laboratory.
Na+, K+, and Cl- were measured in the central laboratory with
the use of a direct ion-selective electrode technique. Albumin
was measured with a bromocresol dye colorimetric technique,
Mg2+ by a formazan dye derivative colorimetric technique,
phosphate by a phosphomolybdate complex colorimetric tech-
nique, and Ca2+ by an Arsenazo III dye colorimetric technique.
Partial arterial CO2 tension and lactate were measured and
base excess was calculated on the Radiometer-ABL 725 ana-
lyzer in the blood gas laboratory.
Quantitative acid–base calculations
Quantitative acid–base analysis was performed as described
by Stewart [18] and later modified by Figge and colleagues
[16] to account for the effects of plasma proteins. The
essence of this approach revolves around the concept that
there are only three independent variables of acid–base sta-
tus: partial pressure of carbon dioxide (pCO2), strong ion dif-
ference (SID), and the total amount of weak acids and proteins
in plasma, mainly comprising albumin and phosphates. The
SID is the net charge balance of all strong ions present, where
a 'strong ion' is one that is completely (or almost completely)
dissociated. This is also described as the apparent SID, SIDa,
and can be represented by the following equation (all concen-
trations in mEq/l):
SIDa = (Na+ + K+ + Ca2+ + Mg2+) - (Cl- + lactate-)
However, this does not account for the role of weak acids in
the balance of electrical charges in plasma water. This is can
Table 1
Baseline demographics and admitting diagnostic category by group
Characteristic Metabolic acidosis: predominant anion No metabolic acidosis
Lactate SIG Chloride
n 239 204 105 303
Age (years) 55.3 60.2 60.8 56.4
Male sex 141 (59) 106 (52) 54 (51) 169 (56)
Admitting diagnostic group
Hepatic 73 (31) 31 (15) 13 (12) 49 (16)
Infectious 36 (15) 43 (21) 18 (17) 51 (17)
Cardiac 30 (13) 21 (10) 10 (10) 33 (11)
General surgery 18 (8) 10 (5) 9 (9) 43 (14)
Respiratory 14 (6) 25 (12) 8 (8) 26 (9)
Other medical 23 (10) 28 (14) 11 (10) 29 (10)
Trauma 10 (4) 7 (3) 17 (16) 21 (7)
Oncology 11 (5) 16 (8) 8 (8) 18 (6)
Neurological 10 (4) 9 (4) 5 (5) 11 (4)
Vascular surgery 8 (3) 3 (1) 2 (2) 15 (5)
Other surgical 6 (3) 11 (5) 4 (4) 4 (1)
Unknown 0 0 0 3 (1)
SIG, strong ion gap. Numbers in parentheses are percentages.
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be expressed through the calculation of the effective SID
(SIDe). The formula for SIDe as determined by Figge and col-
leagues. [16] is as follows:
SIDe = 2.46 × 10-8 × pCO2 (mmHg)/10-pH + (albumin (g/l)) ×
(0.123 × pH - 0.631) + (phosphate (mg/dl)) × (0.309 × pH -
0.469)
This formula accounts quantitatively for the contribution of
weak acids to the electrical charge equilibrium in plasma. The
difference between SIDa and SIDe should range from 0 to 2
mEq/l in healthy patients [17,19], by following the law of elec-
troneutrality. If there are unexplained charges present, they will
be represented by a 'gap' between the SIDa and SIDe; this is
known as the strong ion gap (SIG) [17] and is represented by
the following formula:
SIG = SIDa - SIDe
The traditional anion gap, (Na+ + K+) - (Cl- + HCO3-), does not
account for the effect of weak acids, mostly albumin, which is
commonly abnormal in critical illness.
We then classified patients into four groups depending on the
anion contributing to most acidosis: no metabolic acidosis
defined by SBE ≥ -2 mEq/l; lactic acidosis in which lactate
accounted for more than 50% of SBE; SIG acidosis in which
the SIG (unmeasured ions) accounted for more than 50% of
SBE (and not lactic acidosis); and hyperchloremic acidosis
defined as SBE < -2 mEq/l not explained by lactate or SIG. An
absolute level of chloride was not used for this definition,
because it is the relative relationship between the sodium and
chloride concentrations that contribute to SIDa and thus one of
the independent variables comprising acid–base equilibria
[20]. Thus, if there is a metabolic acidosis present and the SIG
or lactate does not make up most of the acid load, the only
strong ion left is chloride.
Statistical analyses
We compared hospital mortality and length of stay for patients
in each group; by using logistic regression we identified varia-
bles independently associated with mortality in the overall
cohort. Unadjusted mortality between groups of metabolic aci-
dosis was analyzed by χ2 test. Length-of-stay analysis was per-
formed by analysis of variance (MedCalc® version 7.0.1.0). A
logistic regression model was used to identify independent
predictors of mortality. The following variables were explored
and selected by stepwise selection in SAS 8.2 PROC LOGIS-
TIC: age, Na+, K+, Cl-, HCO3-, Mg2+, Ca2+, phosphate, albu-
min, lactate, pCO2, partial pressure of oxygen (pO2), pH, SBE,
SIG, SID, and corrected anion gap (AGc) (all treated as con-
tinuous variables), and ICU type and gender (treated as cate-
gorical variables). Corresponding dummy variables were
created for the categorical variables as necessary. The step-
wise logistic regression analysis was conducted automatically
(variables were entered in the order of relationship to mortal-
ity). Finally, we compared SIG and AGc by Bland–Altman anal-
ysis.
Results
We identified a total of 9,799 ICU admissions during the 18
months. This group of patients had an overall mortality of
14.1%, an average hospital length of stay of 12 days and an
ICU length of stay of 5.8 days. We then identified 851 patients
that fitted entry criteria and, of these, 548 patients (64%) had
metabolic acidosis defined by SBE < -2 mEq/l. Among
patients with metabolic acidosis, lactic acidosis was the most
common (n = 239; 44%) followed by SIG acidosis (n = 204;
37%). Hyperchloremic acidosis was least common (n = 105;
19%). Although length of stay in hospital (32 ± 3 days; mean
± SD) and in ICU (19 ± 4 days) did not vary significantly
between these subgroups of metabolic acidosis or between
acidotic and non-acidotic patients, they did represent a cohort
of patients requiring substantially longer lengths of stay than all
ICU admissions. Overall mortality for patients with suspected
lactic acidosis was 38%. Mortality was significantly higher for
those patients with metabolic acidosis (45%) than for those
without (26%, p < 0.001, odds ratio 2.29; 95% confidence
interval 1.67 to 3.15). Furthermore, mortality varied by major
anion associated with the metabolic acidosis (Figure 1).
Demographics and admission diagnostic categories are
shown by group in Table 1. All three types of metabolic acido-
sis seemed to include a similar case mix except that hepatic
Table 2
Independent predictors of mortality using logistic regression
Variable Value (mean ± SD) Odds ratio 95% CI p
Lactate (mEq/l) 5.7 ± 5.8 1.145 1.107–1.184 <0.0001
Age (years) 57.6 ± 16.4 1.023 1.014–1.034 0.0011
SIG (mEq/l) 5.8 ± 5.2 1.065 1.032–1.099 0.0012
Phosphate (mg/dl) 4.0 ± 2.2 1.214 1.118–1.319 <0.0001
With the use of stepwise logistic regression, these variables were identified as independent predictors of mortality (C statistic = 0.76). The order 
of the variables listed reflects their discriminating value in the model. The odds ratio for phosphate seems larger than the other variables because 
of the narrower distribution of phosphate than that of lactate or SIG. CI, confidence interval; SIG, strong ion gap or unmeasured ions.
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failure patients were over-represented in the lactic acidosis
group and a greater proportion of trauma patients had hyper-
chloremic acidosis. The results of the univariate analysis and
the multivariable logistic regression model are shown in Table
2. This model was developed first by testing for univariate pre-
dictors of mortality. Na+, K+, Cl-, HCO3-, Mg2+, Ca2+, phos-
phate, albumin, lactate, pCO2, pO2, pH, SBE, SIG, SID, AGc,
and age were all predictive in this analysis. However, in the
final model only lactate, age, SIG, and phosphate levels were
independent predictors of mortality. Notably, SBE and pH
were not.
The SIG calculation (see above) is somewhat cumbersome to
use at the bedside [17] and some authors have advocated the
use of simpler techniques based on normalizing the anion gap
for the serum albumin, phosphate, and lactate concentrations
[14,21-23]. Thus, to determine whether AGc could be used in
place of SIG, we repeated our multivariable regression using
AGc in the model in place of SIG. AGc was calculated as fol-
lows: ((Na+ + K+) - (Cl- + HCO3-)) - 2.0 × (albumin (g/dl)) - 0.5
× (phosphate (mg/dl)) - lactate (mEq/l) [14]. As expected, SIG
and AGc had good agreement by Bland–Altman analysis, with
824 of 851 (96.8%) data points contained within 2 SD of the
mean (Figure 2). We also calculated the AGc with an even
simpler formula without the use of phosphate, ((Na+ + K+) -
(Cl- + HCO3-)) - 2.5 × (albumin (g/dl)) - (lactate (mmol/l)) [14],
and also found good agreement between SIG and AGc (sim-
ple, no phosphate), with 821 of 851 (96.5%) of the data
points contained within 2 SD of the mean (Figure 3). Using
either formula can be a practical substitute for SIG at the bed-
side, and the use of AGc did not affect the logistic regression
model when substituted for SIG. Even though agreement was
good, on closer inspection of our classification system the
AGc identified only 172 of the 204 patients (84%) classified
as SIG acidosis. This finding may be the result of cut-off values
used for the definitions of various metabolic acidosis catego-
ries.
Discussion
Previous studies evaluating the association of metabolic aci-
dosis and outcome in the critically ill have focused on either a
specific etiology (for example lactate [24,25]) or a certain
degree of acidosis (for example base excess [7,26,27]). Most
of these studies had small sample sizes and were, of course,
observational in nature. Studies such as these have led to con-
troversy as to whether acidosis is merely a marker for illness
severity or whether it is itself in causal pathway of critical ill-
ness. Experimental evidence suggests that acidosis itself can
influence hemodynamics [11] and innate immunity [13]. Stud-
ies also suggest that different acids are associated with differ-
ent responses [13]. Although no observational study can
establish causation, we sought to determine whether different
types of metabolic acidosis were associated with different
hospital mortality rates. If pH or the degree of metabolic acido-
sis, as characterized by SBE, are themselves significant deter-
minants of outcome, we would expect to see either a similar
mortality across different subtypes of metabolic acidosis or
independent associations as determined by multivariable
regression. We saw neither. Indeed, the two major findings of
our study are that different etiologies of metabolic acidosis are
associated with different mortality rates, and that the severity
Figure 3
Bland–Altman analysis of simplified corrected anion gap (AGc (sim-ple)) and strong ion gap (SIG)
ple)) and strong ion gap (SIG). AGc (simple) was calculated in the 
same was as AGc, but without phosphate. Solid line, mean differences; 
broken lines, ± 1.96 SD. Mean -0.42, SD 1.28, 95% confidence inter-
val (CI) -0.51 to -0.34. Lower limit of agreement = -2.93, 95% CI -3.08 
to -2.79. Upper limit of agreement = 2.08, 95% CI 1.94 to 2.24. This 
shows good agreement between AGc (simple) and SIG, with only 30 
of 851 data points outside 2 SD from the mean.
Figure 2
Bland–Altman analysis of corrected anion gap (AGc) and strong ion gap (SIG)
gap (SIG). Solid line, mean differences; broken lines, ± 1.96 SD. Mean 
-1.36, SD 0.96, 95% confidence interval (CI) -1.42 to -1.29; lower limit 
of agreement = -3.24, 95% CI -3.36 to -3.14. Upper limit of agreement 
= 0.53, 95% CI 0.42 to 0.64. This shows good agreement between 
AGc and SIG, with only 27 of 851 data points outside 2 SD from the 
mean.
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of acidosis, measured by pH or SBE, was not independently
associated with hospital mortality after controlling for the caus-
ative anion (lactate, chloride, or all others). The finding that pH
and SBE were not in the final predictive model may be due to
their strong correlation with all forms of metabolic acidoses.
In comparison with chloride, acidosis due to lactate or other
anions (SIG) was associated with much higher mortality in
hospital (Figure 1). This finding is perhaps not surprising when
the causative anion is lactate, because lactic acidosis has
been known for some time to be associated with high mortality
in this population [24]. However, other anions, measured by
SIG, are not clearly associated with poor outcome in ICU
patients. Whereas some studies have suggested that SIG is
associated with increased mortality in critically ill patients
[1,4,28], other studies have not [2,5]. Hucker and colleagues
[6] have recently also identified a significant difference in SIG
between survivors and non-survivors of patients presenting to
the Emergency Department who required hospital admission
(4.8 versus 8.2 mEq/l, p < 0.001). In our study, the lactate
level and SIG were the variables most strongly associated with
mortality in critically ill patients suspected of having lactic aci-
dosis. Different ICU populations had similar patterns of mortal-
ity associated with the causative anions. Interestingly,
measures of severity of acidosis, namely pH and SBE, were
not predictive in the final model. This result differs from previ-
ous studies [2,5,9,27], perhaps because we sought to quan-
tify all anions (SIG or AGc) for use in our regression model.
When we used only chloride and lactate or used the uncor-
rected anion gap, SBE seemed to be predictive (data not
shown), although the model was less predictive overall.
Overall, hyperchloremic acidosis was associated with mortal-
ity similar to that of the non-acidotic group (29% versus 26%;
p = NS). This is perhaps a reassuring finding because many
cases of hyperchloremic acidosis are iatrogenic – due to the
administration of saline-based intravenous fluids – and can
mostly be avoided by resuscitating with a more balanced solu-
tion such as lactated Ringer's. However, our methods do not
permit us to disentangle the potentially adverse effects of
saline-induced acidosis from the potential advantages of fluid
administration [29]. Indeed, given that our cohort was that of
suspected lactic acidosis, fluid administration might have
reversed shock in some patients at the expense of hyperchlo-
remic acidosis. In this way, saline resuscitation might also have
converted some patients with hypoperfusion-induced lactic
acidosis into hyperchloremia. Against this hypothesis are
numerous observations that lactic acidosis in ICU patients
usually does not reflect hypoperfusion [30-32]. However, we
did not exclude patients whose worst ABG was drawn before
ICU admission (though only patients admitted to the ICU were
included) and thus our cohort may have included some
patients with shock and lactic acidosis and other patients with
saline-induced acidosis after resuscitation. Our database
does not permit us to test this hypothesis directly and further-
more our sample size, although relatively large, is still insuffi-
cient to exclude a clinically significant effect of hyperchloremia
on mortality. It is important to keep in mind that chloride is a
strong anion and, with regards to plasma, the addition of nor-
mal saline increases the value from baseline of chloride more
than that of sodium. This change in the ratio of sodium to chlo-
ride is what is important [20]. The increase in chloride relative
to that of sodium decreases SID, resulting in a decrease in the
alkalinity of blood. In this sense, chloride must always be inter-
preted with the sodium level because they both change with
regard to the patient's volume status and the composition of
intravenous fluids [33].
Length of stay in hospital and in ICU did not differ significantly
between the different groups of metabolic acidosis or even
between the groups that did and did not have metabolic aci-
dosis. This may be explained by our selection process (suspi-
cion of lactic acidosis), which most probably selected a cohort
that was more unwell than the overall ICU population.
The controversy about conflicting results of six previous out-
come studies [1,2,4-6,28] is compounded with our results.
Several key limitations of the some of these previous studies
were discussed by Rocktaeschel and colleagues. [5] and
these authors address several important issues including
small sample size [2,5] and low mortality rates [1]. Even
though Rocktaeschel and colleagues identified a significant
difference in SIG values between survivors and non-survivors,
in their logistic regression model there was a strong correla-
tion between SIG, AG, AGc, and standard base excess
caused by unmeasured anions. These variables are also
strongly linked, making predictive outcomes difficult when all
are included in a simple multivariable analysis. Another inter-
esting observation is the role of gelatin-based resuscitation
fluid and its effect on SIG. Polygeline-based fluids have been
shown to elevate SIG [34], seemingly without increasing mor-
tality. Interestingly, studies that have found that SIG is corre-
lated with outcome were conducted in settings in which
gelatin-based fluids were not used [1,4,6,28], whereas stud-
ies that found no correlation between SIG and outcomes were
conducted in settings in which polygeline-based resuscitation
solutions are common [2,5]. Without controlling for resuscita-
tion strategies that increase the amount of unmeasured ani-
ons, it is difficult to determine whether SIG is a predictor of
mortality.
This study has several limitations. First, as a retrospective
study, our database is limited to the variables that were col-
lected for clinical management, and some patients with meta-
bolic acidosis may have been excluded because of missing
data. However, these were the data available to clinicians and
our study demonstrates that a significant number of patients
suspected of having lactic acidosis clinically do in fact have
other forms of metabolic acidosis. Second, we could not con-
trol for severity of illness between groups. Severity of illness
Available online http://ccforum.com/content/10/1/R22
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scores (for example Acute Physiology and Chronic Health
Evaluation (APACHE)) were recorded only on admission to
ICU and only in a subset of patients. Several patients had their
highest lactate levels several days into their stay in ICU. How-
ever, the use of severity of illness scores are potentially mis-
leading because metabolic acidosis itself might lead to
worsening disease severity. Indeed, most severity scoring sys-
tems take into account acid–base variables and/or lactate.
Thus, for our model we included age as covariate. We also
report the admission diagnostic category in Table 2. The
nature of our database (laboratory values) also limited our
logistic regression model. Ideally we would have included
treatment variables (saline and other resuscitation fluid) as
well as other clinical variables (hemodynamics). Another limita-
tion involved our initial selection process. The 'suspicion of lac-
tic acidosis' excluded several patients in whom a metabolic
acidosis may have been present for other reasons but was not
suspected. The categories of metabolic acidosis were used to
describe the predominating anion. Rather than using an arbi-
trary definition of hyperchloremic metabolic acidosis that relies
on an absolute value of chloride, we first eliminated all other
causes of what has been traditionally classified as an anion
gap metabolic acidosis (SIG or lactate). Our classification
scheme leaves open the possibility that a combined lactic/SIG
acidosis would have been misclassified as hyperchloremic.
Conversely, some hyperchloremic cases could have been mis-
classified as either SIG or lactic acidosis if pre-existing or con-
comitant metabolic alkalosis was also present, decreasing the
apparent impact of chloride. However, these limitations exist
with any acid–base classification scheme and given that
hyperchloremic acidosis is defined on the basis of 'acidosis
without an AG', rather than on the basis of chloride levels,
some imprecision is always going to be present.
The association between serum phosphate and mortality was
somewhat surprising. Because we did not exclude patients
with renal failure, one possible explanation is that elevated
phosphate is a marker for renal insufficiency, leading to the
positive correlation with mortality. However, if we exclude
patients with a phosphate level of more than 5 mg/dl and rean-
alyze with our regression model, the association between
phosphate and mortality remains just as strong. This finding is
therefore not explained satisfactorily. Another possible expla-
nation is that increases in phosphate reflect cellular damage.
For example, increased serum phosphate in patients with
ischemic bowel disease indicates extensive bowel injury [35].
This finding is consistent with the report by Hucker and col-
leagues. [6] that phosphate (among other biochemical and
clinical measurements) was a significant variable in a mortality
prediction model of Emergency Department patients who
required hospital admission.
The 'SIG' category does not in itself identify an individual caus-
ative anion (for example ketones), but rather recognizes the
presence of unidentified anions. The term 'SIG' is in itself
potentially misleading, because the determinants of SIG
include not only strong ions but also weak acids. However, this
terminology has been used with increasing frequency and
introducing new terminology would most probably confuse
rather than clarify. We do not have sufficient information to
exclude the effect of acute renal failure on SIG. Comparing the
distribution of acidosis subtypes between patients with and
without renal dysfunction (defined as a serum creatinine level
of more than 2 mg/dl), we found less hyperchloremic and more
lactic acidosis in the patients with elevated serum creatinine
(Table 3). Interestingly, the proportion of cases defined by ele-
vated SIG was about the same in both groups. These results
are similar to those of Rocktaeschel and colleagues. [36], who
reported metabolic acidosis and high levels of SIG in patients
with acute renal failure. Because patients receiving renal
replacement therapy might have normal blood urea nitrogen
and creatinine levels at the time of the acidosis, we cannot be
sure that they did not have acute renal failure even if the blood
urea nitrogen and creatinine were normal. However, even if we
knew the patient's native renal function, we could not control
for the effect of renal replacement therapy on the SIG. We did
not attempt to quantify the presence of ketones or other ani-
ons that might be present because these data were usually not
available. However, despite these limitations, our study is one
of the largest epidemiologic series of critically ill patients with
metabolic acidosis.
Many previous studies have demonstrated an association
between worsening base excess and mortality. Our study
does not refute this. However, our study provides a potential
explanation for this finding by identifying the causative anion.
Specifically, the base excess does not discriminate between
lactate, SIG, and hyperchloremia. If a patient in shock has less
than 50% of his base excess explained by lactate and the rest
by strong ions other than lactate, then that patient still has an
associated 39% mortality according to our data. To our knowl-
Table 3
Spectrum of metabolic acidosis in patients with and without 
renal dysfunction
Acidosis category Serum creatinine
<2.0 mg/dl (n = 305) ≥2.0 mg/dl (n = 211)
n % n %
Chloride (n = 105) 76 24.9 22 10.4
SIG (n = 204) 105 34.4 83 39.4
Lactate (n = 239) 124 40.7 106 50.2
Renal dysfunction was defined as a serum creatinine level of at least 
2.0 mg/dl at the time at which the electrolytes were drawn. Acidosis 
category is described as the predominant anion associated with the 
metabolic acidosis. SIG, strong ion gap. Percentages are based on 
column totals. The sum of each row is less than the total n because 
of missing data (no contemporaneous creatinine).
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edge, these categories have never before been defined and
associated with outcomes in this way.
Given the strong and independent association between SIG
and mortality in this cohort, it would seem important to monitor
SIG clinically. However, the calculation of SIG is cumbersome
and although easy enough to derive given a computer or pro-
grammable calculator, it seems that correcting the anion gap
for albumin, phosphate, and lactate provided a reasonable sur-
rogate for the SIG. Indeed, perhaps even the phosphate cor-
rection can be omitted in most cases. However, SIG and AGc
show good agreement between the two, and clinically signifi-
cant differences were rarely observed in our cohort (Figures 2
and 3). In fact, most of the lack of fit is demonstrated at the
higher difference values for both the AGc and simplified AGc,
meaning that either alternative may produce higher values than
the SIG calculation (Figures 2 and 3).
Conclusion
Not all metabolic acidoses are the same. In our cohort study,
each type of metabolic acidosis had a different mortality asso-
ciated with it. There was increased mortality associated with
lactate and unidentified anions (SIG). Metabolic acidosis (both
lactic and non-lactic) seems to be associated with high mortal-
ity and increased length of stay in hospital and in the ICU. Like
that of lactate, monitoring of SIG seems warranted and this
can be simplified by the use of an anion gap normalized to the
patient's albumin and phosphate concentrations.
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